Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Broadridge Financial Solutions logoBroadridge Financial Solutions BR

The company said Recurring revenues for the fiscal year rose $235.9 million, or 6%, to $4,222.6 million. Recurring revenue growth on a constant currency basis (Non-GAAP) was 6%, and the company cited Net New Business and Internal Growth in both ICS and GTO as the drivers.

10-KAnnual reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said Recurring revenues for the fiscal year rose $235.9 million, or 6%, to $4,222.6 million. Recurring revenue growth on a constant currency basis (Non-GAAP) was 6%, and the company cited Net New Business and Internal Growth in both ICS and GTO as the drivers.

  2. The company said total operating expenses rose $365.2 million, or 7%, to $5,489.7 million from $5,124.5 million, and cost of revenues increased $297.4 million. The main items were higher ICS postage and distribution expenses of $116.3 million and higher GTO amortization and depreciation expense of $62.8 million.

  3. The company said cash flow from operating activities for the 12 months rose $232.9 million. Cash flow used in financing activities decreased $140.8 million, and the company explained that a $461.0 million increase in cash used for share repurchases was partly offset by a $325.0 million increase in net borrowings.

  4. The company said it acquired AdvisorTarget in May 2024, and the consideration included $34.3 million in cash and contingent consideration of up to $30.5 million. In the same month, it announced the proposed acquisition of Kyndryl SIS for approximately $200 million, which remains subject to closing conditions, including regulatory approvals.

Key figures

Fiscal year ended June 30, 2024

Revenue
$6.5B
Operating income
$1.0B
Net income
$698M
EPS
$5.86
Operating cash flow
$1.1B

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Recurring revenues rose 6% for the year

The company said Recurring revenues for the fiscal year rose $235.9 million, or 6%, to $4,222.6 million. Recurring revenue growth on a constant currency basis (Non-GAAP) was 6%, and the company cited Net New Business and Internal Growth in both ICS and GTO as the drivers.

Source · Based on the MD&A text of the filing

Operating expenses and cost of revenues rise

The company said total operating expenses rose $365.2 million, or 7%, to $5,489.7 million from $5,124.5 million, and cost of revenues increased $297.4 million. The main items were higher ICS postage and distribution expenses of $116.3 million and higher GTO amortization and depreciation expense of $62.8 million.

Source · Based on the MD&A text of the filing

Annual operating cash flow up, financing outflows

The company said cash flow from operating activities for the 12 months rose $232.9 million. Cash flow used in financing activities decreased $140.8 million, and the company explained that a $461.0 million increase in cash used for share repurchases was partly offset by a $325.0 million increase in net borrowings.

Source · Based on the MD&A text of the filing

AdvisorTarget acquisition and Kyndryl SIS announcement

The company said it acquired AdvisorTarget in May 2024, and the consideration included $34.3 million in cash and contingent consideration of up to $30.5 million. In the same month, it announced the proposed acquisition of Kyndryl SIS for approximately $200 million, which remains subject to closing conditions, including regulatory approvals.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.